Activity of the mammalian DNA transposon piggyBat from Myotis lucifugus is restricted by its own transposon ends

A Alison B. Hickman L Laurie Lannes C Christopher M. Furman C Christina Hong L Lidiya Franklin R Rodolfo Ghirlando A Arpita Ghosh W Wentian Luo (Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center) P Parthena Konstantinidou H Hernan A. Lorenzi A Anne Grove A Astrid D. Haase M Matthew H. Wilson (Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center) F Fred Dyda

Abstract

AbstractMembers of the piggyBac superfamily of DNA transposons are widely distributed in host genomes ranging from insects to mammals. The human genome has retained five piggyBac-derived genes as domesticated elements although they are no longer mobile. Here, we have investigated the transposition properties of piggyBat from Myotis lucifugus, the only known active mammalian DNA transposon, and show that its low activity in human cells is due to subterminal inhibitory DNA sequences. Activity can be dramatically improved by their removal, suggesting the existence of a mechanism for the suppression of transposon activity. The cryo-electron microscopy structure of the piggyBat transposase pre-synaptic complex showed an unexpected mode of DNA binding and recognition using C-terminal domains that are topologically different from those of the piggyBac transposase. Here we show that structure-based rational re-engineering of the transposase through the removal of putative phosphorylation sites and a changed domain organization - in combination with truncated transposon ends - results in a transposition system that is at least 100-fold more active than wild-type piggyBat.

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 07, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (14)

A

Alison B. Hickman

L

Laurie Lannes

C

Christopher M. Furman

C

Christina Hong

L

Lidiya Franklin

R

Rodolfo Ghirlando

A

Arpita Ghosh

W

Wentian Luo

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center

P

Parthena Konstantinidou

H

Hernan A. Lorenzi

A

Anne Grove

A

Astrid D. Haase

M

Matthew H. Wilson

Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center

F

Fred Dyda